EGFR and cancer: al. reported an enzyme prodrug system (Fcy-EGF/5-FC), which is a fusion protein composed yeast cytosine deaminase fused with human epidermal growth factor (Fcy-hEGF) and capable of targeting and killing EGFR-overexpressing cancer through converting 5-FC to 1000-fold toxic 5-FU.